
This fund aims to closely track the investment returns – both capital appreciation and income – of its underlying index, prior to the deduction of management fees and other operating costs. To achieve this, it typically commits a minimum of 80% of its total assets to the securities that constitute this benchmark. The index itself consists of a collection of companies that have recently gone public through an Initial Public Offering (IPO) and are traded on a U.S. stock exchange. It is classified as a non-diversified fund.
Is IPO's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

UK university spinouts attracted £1.56 billion of investment in the first half of 2026, but funding for new ventures collapsed by more than two-thirds, according to research published by IP Group PLC (LSE:IPO) and its fund management subsidiary Parkwalk. Investment climbed 38.2% from the second half of 2025 to its second-highest half-year level in a decade, approaching the £1.58 billion record set in 2021.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES YORK SPACE SYSTEMS (YSS) INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM PRIOR TO OCT. 30 LEAD PLAINTIFF D

Data center backlash is delaying projects, but AI demand is shifting capital toward the companies solving the buildout's bottlenecks.

IP Group PLC (LSE:IPO) has invested £4 million in a £36 million funding round for portfolio company Microbiotica, backing the development of a potential new treatment for ulcerative colitis. The Series C financing, led by British Business Bank, will support the progression of Microbiotica's lead drug candidate, MB310, into Phase 2 clinical trials following encouraging early-stage results.

IP Group PLC (LSE:IPO) has led a £4 million funding round in Matter Machine, a University of Liverpool spin-out using artificial intelligence to accelerate the discovery of new materials. The oversubscribed pre-Series A financing also attracted backing from Northern Gritstone, Norrsken Evolve, LYVA Labs and other investors, with proceeds earmarked for expanding the company's team, developing its technology and building commercial partnerships.